A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-021 as a Single Agent and in Combination Therapy in Patients with Advanced Solid Tumors.

2024-517339-30-00 Protocol AVZO-021-1001 Phase I and Phase II (Integrated) - First administration to humans Authorised, recruitment pending

Status Authorised, recruitment pending · 5 EU/EEA countries · 32 sites · Protocol AVZO-021-1001

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - First administration to humans
Status Authorised, recruitment pending
Participants planned 354
Countries 5
Sites 32

Advanced Solid Tumors

Key facts

Sponsor
Avenzo Therapeutics Inc.
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Decision date (initial)
2025-03-10
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-517339-30-00
ClinicalTrials.gov
NCT05867251

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Advanced Solid Tumors

VersionLevelCodeTermSystem organ class
21.1 LLT 10065252 Solid tumor 10029104

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Avenzo Therapeutics Inc.

Sponsor organisation
Avenzo Therapeutics Inc.
Address
12707 High Bluff Drive Suite 200
City
San Diego
Postcode
92130-2037
Country
United States

Scientific contact point

Organisation
Avenzo Therapeutics Inc.
Contact name
Naresh Nayyar

Public contact point

Organisation
Avenzo Therapeutics Inc.
Contact name
Naresh Nayyar

Locations

5 EU/EEA countries · 32 investigational sites

By country

CountryMS statusPlanned subjectsSites
Belgium Authorised, recruitment pending 11 4
France Authorised, recruitment pending 11 7
Germany Authorised, recruitment pending 10 4
Italy Authorised, recruitment pending 10 5
Spain Authorised, recruitment pending 10 12
Rest of world
Australia, Korea, Republic of, United States
302

Investigational sites

Belgium

4 sites · Authorised, recruitment pending
Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur
Gynaecological oncology, Place Louise Godin 15, 5000, Namur
UZ Leuven
Gynaecological oncology, Herestraat 49, 3000, Leuven
Cliniques universitaires Saint-Luc
Gynaecological oncology, Avenue Hippocrate 10, 1200, Brussels
Antwerp University Hospital
Gynaecological oncology, Drie Eikenstraat 655, 2650, Edegem

France

7 sites · Authorised, recruitment pending
Institut Gustave Roussy
Department of Medecine, 114 Rue Edouard Vaillant, 94800, Villejuif
Centre Georges François Leclerc
Medical Oncology, 1 rue Professeur Marion, 21079, Dijon
Oncopole Claudius Regaud
Oncology, 1 Avenue Irene Joliot Curie, 31059, Toulouse Cedex 9
Centre Leon Berard
Medical Oncology, 28 Rue Laennec, 69008, Lyon
Institut De Cancerologie De L Ouest
Medical Oncology, Boulevard Jacques Monod, 44805, Saint-Herblain Cedex
Institut Paoli Calmettes
Medical Oncology, 232 Boulevard De Sainte Marguerite, Bp 156, Marseille
Institut Bergonié
Medical Oncology, 229 cours de l'Argonne, 33076, Bordeaux

Germany

4 sites · Authorised, recruitment pending
Universitaetsklinikum Erlangen AöR
Gynecology, Universitaetsstrasse 21-23, Innenstadt, Erlangen
University Hospital Düsseldorf
Gynecological oncology, Moorenstr. 5, 40225, Dusseldorf
Uniklinikum Leipzig
Gynecology, Liebigstrasse 20, 04103, Leipzig
Universitätsklinikum Augsburg
Gynacology, Stenglinstr. 2, 86156, Augsburg

Italy

5 sites · Authorised, recruitment pending
Istituto Europeo Di Oncologia S.r.l.
Divisione di Sviluppo Nuovi Farmaci per Terapie Innovative, Via Giuseppe Ripamonti 435, 20141, Milan
Azienda Ospedaliero-Universitaria Maggiore Della Carita
Oncology Division, Corso Giuseppe Mazzini 18, 28100, Novara
Istituto Di Candiolo Fondazione Del Piemonte Per L'Oncologia IRCCS
Oncology, Strada Provinciale 142 Orba Km 3,95, 10060, Candiolo
Azienda Ospedaliero Universitaria Delle Marche
Medicina Intenra - SOD Clinica Oncologica, Via Conca 71, 60126, Ancona
Azienda Ospedaliero Universitaria Di Modena
Oncology, Largo Del Pozzo 71, 41124, Modena

Spain

12 sites · Authorised, recruitment pending
Hospital Hm Nou Delfos
Medical Oncology, Avinguda De Vallcarca 151, 08023, Barcelona
Clinica Universidad De Navarra
Medical Oncology, Calle Marquesado De Santa Marta 1, 28027, Madrid
Hospital Beata Maria Ana
Medical Oncology, Calle Del Doctor Esquerdo No. 83, 28007, Madrid
Hospital General Universitario Gregorio Maranon
Medical Oncology, Calle Del Doctor Esquerdo 46, 28007, Madrid
Hospital Clinico San Carlos
Medical Oncology, Calle Del Profesor Martín Lagos S/n, 28040, Madrid
Hospital Universitario 12 De Octubre
Medical Oncology, Avenida De Cordoba Sn, 28041, Madrid
Fundacion Instituto Valenciano De Oncologia
Medical Oncology, Calle Professor Beltran Baguena 8, 46009, Valencia
Hospital Universitario Hm Sanchinarro
Medical Oncology, Calle Ona 10, 28050, Madrid
Hospital Universitari Vall D Hebron
Medical Oncology, Passeig De La Vall D'Hebron 119-129, 08035, Barcelona
University Hospital Virgen Del Rocio S.L.
Medical Oncology, Avenida De Manuel Siurot S/n, 41013, Sevilla
Hospital Universitario Fundacion Jimenez Diaz
Medical Oncology, Avenida De Los Reyes Catolicos 2, 28040, Madrid
Clinica Universidad De Navarra
Medical Oncology, Pio XII Etorbidea 36, 31008, Pamplona

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-10-25 Spain Acceptable with conditions
2025-03-03
2025-03-03
2 SUBSTANTIAL MODIFICATION SM-1 2025-10-02 Spain Acceptable with conditions
2025-12-18
2025-12-19
3 SUBSTANTIAL MODIFICATION SM-2 2026-03-11 Spain Acceptable
2026-05-05
2026-05-05